Etoposide

Concentrate for solution for infusion 20 mg/ml

Etoposide may be used in treatment of small-cell lung cancer, resistant nonseminomatous
testicular carcinoma, acute myelomonocytic and monocytic leukaemia (AML, FAB
subtype M4 or M5) as part of combination therapy after failure of induction chemotherapy.